NCT06201507 2024-01-12
BV-AVD-R Treatment Children Hodgkin's Lymphoma
Beijing Children's Hospital
Phase 2 Unknown
Clinical Trials
7 trialsNCT05006664 2021-09-01
Brentuximab Vedotin in Combination With CHEP in Patient With PTCL
Czech Lymphoma Study Group
Phase 2 Unknown
NCT03474133 2020-07-21
BASALT
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 2 Unknown
NCT01476410 2020-02-17
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Northwestern University
Phase 2 Unknown
NCT03527628 2019-11-18
(Optimist)
King Abdullah International Medical Research Center
Phase 2 Unknown
NCT03540849 2018-05-30
BV-ALLO
University Hospital, Caen
Phase 2 Unknown
NCT02275598 2014-10-27
Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma
University of Modena and Reggio Emilia
Phase 2 Unknown